Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Acad Radiol ; 8(6): 473-7, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11394539

RESUMEN

RATIONALE AND OBJECTIVES: The authors performed this study to evaluate the mortality and morbidity associated with a simple technique for inducing diabetes in dogs--suprarenal intraarterial infusion of alloxan and streptozotocin during balloon occlusion of the juxtarenal abdominal aorta. MATERIALS AND METHODS: The authors attempted to induce diabetes in six purpose-bred dogs. After the dogs were fasted for 12 hours, the abdominal aorta at the level of the origin of the renal arteries was occluded with an angioplasty balloon introduced by means of a femoral approach. A 3-F microcatheter (n = 1) or infusion wire (n = 5) was introduced via the percutaneous transluminal angioplasty catheter and positioned at the level of the celiac axis, and a mixture of streptozotocin (20-25 mg/kg) and alloxan (20-25 mg/kg) was infused. Diabetes was considered to have been induced if the dogs experienced sustained hyperglycemia. RESULTS: There were no deaths during the follow-up period (range, 7 months to 2 1/2 years). A diabetes-like state was induced in five of the six dogs, and no nephrotoxicity was seen. Diabetes was not induced in one dog owing to caudal migration of an undersized balloon during the infusion; this also resulted in reversible renal damage. CONCLUSION: This simple technique is effective for inducing diabetes in dogs, and morbidity and mortality rates are lower than those reported in the literature with other described techniques.


Asunto(s)
Aloxano/administración & dosificación , Aorta Abdominal/fisiología , Oclusión con Balón , Diabetes Mellitus Experimental/inducido químicamente , Infusiones Intraarteriales/métodos , Estreptozocina/administración & dosificación , Animales , Diabetes Mellitus Experimental/mortalidad , Perros , Femenino
2.
J Thorac Imaging ; 14(1): 63-8, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9894954

RESUMEN

Missed lung cancer is an important medicolegal issue and is the second leading cause for malpractice actions against radiologists. Contributing factors to overlooked lung cancer can be ascribed to observer performance, lesion characteristics, and technical considerations. Of these, errors related to observer performance are probably the most important. Missed lung cancer does not necessarily constitute malpractice, but lesions of high conspicuity are more likely to be associated with an adverse legal outcome. Multiple strategies have been advocated to reduce the frequency of missed lung cancer. Several studies have emphasized the importance of careful comparison of the current radiograph with one or more prior examinations.


Asunto(s)
Medicina Legal , Neoplasias Pulmonares/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Competencia Clínica , Errores Diagnósticos , Estudios de Seguimiento , Humanos , Mala Praxis/legislación & jurisprudencia , Radiografía Torácica , Radiología/legislación & jurisprudencia , Nódulo Pulmonar Solitario/diagnóstico por imagen , Tecnología Radiológica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...